In HCS Pharma we strongly believe that 3D cell culture is the right way to improve drug dicovery processes. Moreover, we know that our 3D HydroscaffoldTM matrix BIOMIMESYS® could be useful for bioproduction. We will be happy Read more…
This is the end of Rania‘s 6-month internship in HCS Pharma about a new liver biochip system. After a first publication “Development of Liver-on-Chip Integrating a Hydroscaffold Mimicking the Liver’s Extracellular Matrix” in collaboration with Read more…
BIOMIMESYS® has taken place in the panel of the future medicine on the 27th of September. The next step has arrived, and Nathalie Maubon CEO of HCS Pharma has taken BIOMIMESYS® all the way to Read more…
1 Comment
Back from ATAE conference by Adebiotech - HCS Pharma · June 22, 2023 at 3:26 pm
[…] project director Elodie was pleased to present our poster entitled “Bridging the gap between in vitro & in vivo: 3D cell culture considering … there, which attracted the attention from the audience. The results show, with the example of in […]